Clinical Trial

Renal Oximetry-Guided Anesthesia With Near-Infrared Spectroscopy for Improved Postoperative Outcomes

Study acronym: ROGAR
Completed Phase 1
View on ClinicalTrials.gov →
Summary
The trial is a prospective, randomized, single-blind, pilot study investigating whether near-infrared spectroscopy (NIRS)-guided optimization of intraoperative renal oxygen saturation reduces postoperative acute kidney injury (AKI) in patients undergoing elective hepatectomy. The trial will enroll 80 adults (≥45 years, American society of Aneshesiologists physical status I-III), randomizing them to either standard anesthesia management or NIRS-guided management where a predefined 6-step intervention protocol (volume optimization, vasoactive drugs, inotropes, heart rate management, transfusion, and FiO₂ management) is triggered if decreases \>10% from baseline. Primary outcomes are the incidence of AKI within 7 days and the 28-day Comprehensive Complication Index (CCI). The study aims to determine if real-time SrtO₂ monitoring and proactive intervention can prevent this serious complication, based on previous observational data linking renal desaturation to AKI risk.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-25.
Status change: Not Yet Recruiting → Completed 2026-05-05
Trial Details
NCT Number NCT07141693
Lead Sponsor Chinese PLA General Hospital
Collaborators: Beijing Tsinghua Changgeng Hospital
Conditions Acute Kidney Injury
Enrollment 80 participants
Start Date 2025-09-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-04-24 (estimated)
Updated on ClinicalTrials.gov 2026-05-08